300
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Role of gamma knife radiosurgery for recurrent or residual World Health Organization grade II and III intracranial meningiomas

, , , , &
Pages 239-245 | Received 17 Sep 2018, Accepted 03 Feb 2020, Published online: 13 Feb 2020

References

  • Milker-Zabel S, Zabel A, Schulz-Ertner D, et al. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys 2005;61:809–16.
  • Pasquier D, Bijmolt S, Veninga T, et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2008;71:1388–93.
  • Hoe Y, Choi YJ, Kim JH, et al. Peritumoral brain edema after stereotactic radiosurgery for asymptomatic intracranial meningiomas: risks and pattern of evolution. J Korean Neurosurg Soc 2015;58:379–84.
  • Modha A, Gutin PH. Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 2005;57:538–50.
  • Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol 2015;17:iv1–iv62.
  • Rogers L, Gilbert M, Vogelbaum MA. Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol 2010;99:393–405.
  • Kim M, Cho YH, Kim JH, Kim CJ, Kwon DH. Analysis the causes of radiosurgical failure in intracranial meningiomas treated with radiosurgery. Clin Neurol Neurosurg 2017;154:51–8.
  • Hasegawa H, Hanakita S, Shin M, et al. Single-fractionated stereotactic radiosurgery for intracranial meningioma in elderly patients: 25-year experience at a single institution. Oper Neurosurg (Hagerstown) 2018;14:341–50.
  • Ali S, Nassar A, Siddiqui MT. Crush preparations of meningiomas: can grading be accomplished? Diagn Cytopathol 2008;36:827–31.
  • Sheehan JP, Williams BJ, Yen CP. Stereotactic radiosurgery for WHO grade I meningiomas. J Neurooncol 2010;99:407–16.
  • Starke RM, Williams BJ, Hiles C, et al. Gamma knife surgery for skull base meningiomas. J Neurosurg 2012;116:588–97.
  • Bartolomei M, Bodei L, De Cicco C, et al. Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma. Eur J Nucl Med Mol Imaging 2009;36:1407–16.
  • Lee S, Kwon DH, Kim CJ, Kim JH. Long-term outcomes following Gamma Knife radiosurgery for small, newly diagnosed meningiomas. Clin Neurol Neurosurg 2016;142:1–7.
  • Lee KD, DePowell JJ, Air EL, et al. Atypical meningiomas: is postoperative radiotherapy indicated? Neurosurg Focus 2013;35:E15.
  • Goldbrunner R, Minniti G, Preusser M, et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 2016;17:e383–91.
  • Attia A, Chan MD, Mott RT, et al. Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery. J Neurooncol 2012;108:179–85.
  • Hanakita S, Koga T, Igaki H, et al. Role of gamma knife surgery for intracranial atypical (WHO grade II) meningiomas. J Neurosurg 2013;119:1410–4.
  • Huffmann BC, Reinacher PC, Gilsbach JM. Gamma knife surgery for atypical meningiomas. J Neurosurg 2005;102: 283–6.
  • Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22–39.
  • Al-Mefty O, Kadri PA, Pravdenkova S, et al. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 2004;101:210–8.
  • Kondziolka D, Lunsford LD, Coffey RJ, Flickinger JC. Gamma knife radiosurgery of meningiomas. Stereotact Funct Neurosurg 1991;57:11–21.
  • Palma L, Celli P, Franco C, Cervoni L, Cantore G. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 1997;86:793–800.
  • Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109.
  • Nagar VA, Ye JR, Ng WH, et al. Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation. AJNR Am J Neuroradiol 2008;29:1147–52.
  • Borovich B, Doron Y, Braun J, et al. Recurrence of intracranial meningiomas: the role played by regional multicentricity. Part 2: Clinical and radiological aspects. J Neurosurg 1986;65:168–71.
  • Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994;80:195–201.
  • Nanda A, Bir SC, Konar S, et al. Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence. J Clin Neurosci 2016;31:112–21.
  • Hardesty DA, Wolf AB, Brachman DG, et al. The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg 2013;119:475–81.
  • Choi CY, Soltys SG, Gibbs IC, et al. Cyberknife stereotactic radiosurgery for treatment of atypical (WHO grade II) cranial meningiomas. Neurosurgery 2010;67:1180–8.
  • Hug EB, Devries A, Thornton AF, et al. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 2000;48:151–60.
  • Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ. Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 1996;34:817–22.
  • Ding D, Starke RM, Hantzmon J, et al. The role of radiosurgery in the management of WHO Grade II and III intracranial meningiomas. Neurosurg Focus 2013;35:E16.
  • Zhang M, Ho AL, D'Astous M, et al. CyberKnife stereotactic radiosurgery for atypical and malignant meningiomas. World Neurosurg 2016;91:574–81.e1.
  • Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. Cancer 2012;118:1048–54.
  • Durand A, Labrousse F, Jouvet A, et al. WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 2009;95:367–75.
  • Hakim R, Alexander E, Loeffler JS, et al. Results of linear accelerator-based radiosurgery for intracranial meningiomas. Neurosurgery 1998;42:446–53.
  • Ojemann SG, Sneed PK, Larson DA, et al. Radiosurgery for malignant meningioma: results in 22 patients. J Neurosurg 2000;93: 62–7.
  • Aghi MK, Carter BS, Cosgrove GR, et al. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 2009;64:56–60.
  • Jaaskelainen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 1986;25:233–42.
  • Mahmood A, Caccamo DV, Tomecek FJ, Malik GM. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 1993;33:955–63.
  • Rohringer M, Sutherland GR, Louw DF, Sima AA. Incidence and clinicopathological features of meningioma. J Neurosurg 1989;71:665–72.
  • Younis GA, Sawaya R, DeMonte F, et al. Aggressive meningeal tumors: review of a series. J Neurosurg 1995;82:17–27.
  • Peyre M, Salaud C, Clermont-Taranchon E, et al. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Oncotarget 2015;6:32713–22.
  • Valery CA, Faillot M, Lamproglou I, et al. Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm. J Neurosurg 2016;125:89–96.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.